Evaxion A/S (NASDAQ: EVAX) announced that its AI-Immunology platform achieved an 86% success rate in identifying vaccine targets that trigger ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE